Business Information
The group's principal activities are to manufacture and market pharmaceutical products. The group's business segments include research, generic formulations, branded formulations, bulk actives, custom chemical synthesis, critical care, biotechnology and diagnostics. The operations span 65 countries, including the United States, Europe and Japan. The group has 6 multi-ton manufacturing facilities. In fiscal 2004, the group acquired trigenesis therapeutics inc.
|
|
Name |
Title
|
Email
|
| Anji Reddy | Chmn. | N/A | | G. Prasad | Vice Chmn., CEO | N/A | | Abhijit Mukherjee | Pres. - Chemical Technical Operations | N/A | | Arun Sawhney | Pres. - Active Pharmaceutical Ingredients | N/A | | Jaspal Bajwa | Pres. - Branded Formulations, RoW | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 546,009 | 36,649 | | 2005 | 446,399 | 4,843 | | 2004 | 462,702 | 57,008
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
